S G Sydserff

729 total citations
16 papers, 546 citations indexed

About

S G Sydserff is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, S G Sydserff has authored 16 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in S G Sydserff's work include Neuroscience and Neuropharmacology Research (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Neurological Disease Mechanisms and Treatments (4 papers). S G Sydserff is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Neurological Disease Mechanisms and Treatments (4 papers). S G Sydserff collaborates with scholars based in United States, Canada and United Kingdom. S G Sydserff's co-authors include A.J. Cross, A R Green, Thomas J. Hudzik, Krista L. Gilby, Dan Widzowski, Gene C. Palmer, B. Anthony Bell, Richard Green, Ladislav Mrzljak and H.A. Robertson and has published in prestigious journals such as Stroke, Brain Research and Annals of the New York Academy of Sciences.

In The Last Decade

S G Sydserff

16 papers receiving 530 citations

Peers

S G Sydserff

CMN

NEURO

EPIDE

NEURO

Roi Ann Wallis United States

Kimberly L. Panizzon United States

Siesjø Bk Sweden

Sara M. Beni Israel

Hisato Yanase Japan

Jake T. Neumann United States

Seishi Katsumata Japan

Kristal D. Atkins United States

Gerhard Wilhelm Bielenberg Germany

Fen‐Lei Chang United States

Roi Ann Wallis United States

S G Sydserff

257 ×1.2

250 ×1.3

CMN

149 ×0.8

NEURO

52 ×0.5

EPIDE

87 ×1.1

NEURO

Citations per year, relative to S G Sydserff S G Sydserff (= 1×) peers Roi Ann Wallis

Countries citing papers authored by S G Sydserff

Since Specialization

Citations

This map shows the geographic impact of S G Sydserff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S G Sydserff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S G Sydserff more than expected).

Fields of papers citing papers by S G Sydserff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S G Sydserff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S G Sydserff. The network helps show where S G Sydserff may publish in the future.

Co-authorship network of co-authors of S G Sydserff

This figure shows the co-authorship network connecting the top 25 collaborators of S G Sydserff. A scholar is included among the top collaborators of S G Sydserff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S G Sydserff. S G Sydserff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Sydserff, S G, Min Ding, David C. Perry, et al.. (2011). Ultra-low exposure to alpha-7 nicotinic acetylcholine receptor partial agonists elicits an improvement in cognition that corresponds with an increase in alpha-7 receptor expression in rodents: implications for low dose clinical efficacy. Neuroscience. 186. 76–87. 29 indexed citations

Sydserff, S G, Dekun Song, Michael C. Quirk, et al.. (2009). Selective α7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes. Biochemical Pharmacology. 78(7). 880–888. 81 indexed citations

Gilby, Krista L., et al.. (2009). Postnatal epigenetic influences on seizure susceptibility in seizure-prone versus seizure-resistant rat strains.. Behavioral Neuroscience. 123(2). 337–346. 27 indexed citations

Gilby, Krista L., S G Sydserff, & H.A. Robertson. (2005). Differential neuroprotective effects for three GABA-potentiating compounds in a model of hypoxia–ischemia. Brain Research. 1035(2). 196–205. 18 indexed citations

Sydserff, S G, et al.. (2002). Effect of NXY‐059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window. British Journal of Pharmacology. 135(1). 103–112. 120 indexed citations

Tuor, Ursula I., Thomas J. Hudzik, Krisztina L. Malisza, et al.. (2001). Long-Term Deficits Following Cerebral Hypoxia–Ischemia in Four-Week-Old Rats: Correspondence between Behavioral, Histological, and Magnetic Resonance Imaging Assessments. Experimental Neurology. 167(2). 272–281. 22 indexed citations

Sydserff, S G, et al.. (2000). Clomethiazole is neuroprotective in models of global and focal cerebral ischemia when infused at doses producing clinically relevant plasma concentrations. Brain Research. 862(1-2). 59–62. 21 indexed citations

Hudzik, Thomas J., Dan Widzowski, S G Sydserff, et al.. (2000). Long-Term Functional End Points Following Middle Cerebral Artery Occlusion in the Rat. Pharmacology Biochemistry and Behavior. 65(3). 553–562. 44 indexed citations

Palmer, Gene C., et al.. (1999). The Low‐Affinity, Use‐Dependent NMDA Receptor Antagonist AR‐R 15896AR: An Update of Progress in Stroke. Annals of the New York Academy of Sciences. 890(1). 406–420. 15 indexed citations

10.

Sydserff, S G, et al.. (1999). Efficacy of AR-R15896AR in the rat monofilament model of transient middle cerebral artery occlusion. Journal of Stroke and Cerebrovascular Diseases. 8(6). 388–397. 8 indexed citations

11.

Sydserff, S G, Richard Green, & A.J. Cross. (1996). The Effect of Oedema and Tissue Swelling on the Measurement of Neuroprotection; a Study using Chlormethiazole and Permanent Middle Cerebral Artery Occlusion in Rats. PubMed. 5(1). 81–85. 21 indexed citations

12.

Sydserff, S G, et al.. (1995). The effect of chlormethiazole on neuronal damage in a model of transient focal ischaemia. British Journal of Pharmacology. 114(8). 1631–1635. 55 indexed citations

13.

Sydserff, S G, et al.. (1995). The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the rat. PubMed. 4(3). 323–328. 57 indexed citations

14.

Sydserff, S G, et al.. (1994). Calcitonin gene-related peptide reduces brain injury in a rat model of focal cerebral ischemia.. Stroke. 25(10). 2055–2058. 24 indexed citations

15.

Sydserff, S G, et al.. (1993). Rat models of middle cerebral artery ischemia.. Stroke. 24(9). 1423–1424. 2 indexed citations

16.

Sydserff, S G, et al.. (1992). Focal ischaemic cerebral blood flow can be increased by CGRP. Neuropeptides. 22(1). 65–65. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact